Results 81 to 90 of about 276,101 (206)
Molecular analyses of hematological malignancies [PDF]
Cataloged from PDF version of article.Includes bibliographical references leaves 131-140Normal hematopoiesis is known to be disrupted in hematological malignancies.
Yılmaz, Z. Buket
core
Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin +14 more
wiley +1 more source
Intracranial hemorrhage in adult patients with hematological malignancies
Background: Clinical characteristics and outcomes of intracranial hemorrhage (ICH) among adult patients with various hematological malignancies are limited. Methods: A total of 2,574 adult patients diagnosed with hematological malignancies admitted to a
蔡偉 ;戴春暉 ;姚明 ;陳建源 ;田蕙芬 ;黃聖懿 ;唐季祿 +1 more
core +1 more source
Objective Race and household income impact outcomes in patients with rheumatic conditions; however, their role in pediatric antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) remains poorly understood. We aimed to evaluate whether race and ethnicity and household income are associated with severe AAV disease and renal outcomes among
Roberto Alejandro Valdovinos +2 more
wiley +1 more source
Cancer associated fibroblasts in hematological malignancies
Tumor microenvironment plays an important role in cancer initiation and progression. In hematological malignancies, the bone marrow represents the paradigmatic anatomical site in which tumor microenvironment expresses its morphofunctional features. Among
RIBATTI, Domenico +3 more
core
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato +27 more
wiley +1 more source
Precision diagnosis and treatment for hematological malignancies
With the in-depth research on the pathogenesis of hematological malignancies, precision diagnosis and stratified treatment have been continuously enhanced and optimized over the years.
ZHANG Xi
core +1 more source
Objective Elevated C‐reactive protein (CRP) levels in systemic sclerosis (SSc) have been linked with severe disease and worse survival, but the role of platelet levels remains unclear. This study examined whether elevated platelet levels, CRP levels, or both are associated with disease severity, progression, and survival in SSc.
Brian S. Lee +4 more
wiley +1 more source
Objective Systemic lupus erythematosus (SLE) significantly impacts employment capacity. This study aimed to investigate the impact of burden of disease activity, damage, and treatment on employment outcomes and transitions in patients with SLE. Methods Using data from a single center, we analyzed employment transitions, adjusted mean disease activity ...
Javier Mencia‐Ledo +4 more
wiley +1 more source
Hematological Malignancies: Molecular Mechanisms and Therapy
Hematological malignancies comprise a wide range of relatively rare cancers with a diverse spectrum of biological and clinical presentations [...
Stella Bouziana
core +1 more source

